458 related articles for article (PubMed ID: 3962948)
21. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
22. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
[TBL] [Abstract][Full Text] [Related]
23. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
Madalinski K; Burczynska B; Heermann KH; Uy A; Gerlich WH
Clin Exp Immunol; 1991 Jun; 84(3):493-500. PubMed ID: 2044231
[TBL] [Abstract][Full Text] [Related]
24. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
[TBL] [Abstract][Full Text] [Related]
25. Natural history of hepatitis B in perinatally infected carriers.
Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
[TBL] [Abstract][Full Text] [Related]
26. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
Hasçelik G; Günalp A
Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.
Maimone S; Calvaruso V; Pleguezuelo M; Squadrito G; Amaddeo G; Jacobs M; Khanna P; Raimondo G; Dusheiko G
J Viral Hepat; 2009 Nov; 16(11):769-74. PubMed ID: 19709363
[TBL] [Abstract][Full Text] [Related]
28. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
[No Abstract] [Full Text] [Related]
29. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
Brown SD; Barbara AJ; Lambert T; Wilson DV
Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
[TBL] [Abstract][Full Text] [Related]
31. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
[TBL] [Abstract][Full Text] [Related]
32. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629
[TBL] [Abstract][Full Text] [Related]
33. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
35. Effects of alcohol on the liver in HBsAg carriers.
Itoh S; Shimoji K
Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
[TBL] [Abstract][Full Text] [Related]
36. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
37. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
[TBL] [Abstract][Full Text] [Related]
38. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
[TBL] [Abstract][Full Text] [Related]
39. Markers of disease activity in chronic hepatitis B virus infection.
Yalcin K; Degertekin H; Yildiz F; Celik Y
Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
[TBL] [Abstract][Full Text] [Related]
40. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
Zanetti AR
Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
